Spero Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Spero Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2018 to Q3 2024.
  • Spero Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $153K, a 64.7% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $153K -$281K -64.7% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $434K -$5.31M -92.4% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $434K -$5.31M -92.4% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $435K -$5.31M -92.4% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $434K -$5.31M -92.4% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $5.74M +$273K +4.99% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $5.74M -$189K -3.19% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $5.74M +$96K +1.7% Dec 31, 2022 10-K 2024-03-13
Q3 2022 $5.74M +$527K +10.1% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $5.47M +$256K +4.91% Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $5.93M +$717K +13.8% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $5.64M +$432K +8.29% Dec 31, 2021 10-K 2023-03-30
Q3 2021 $5.21M +$1K +0.02% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $5.21M +$133K +2.62% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $5.21M +$468K +9.87% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $5.21M +$1.69M +48.1% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $5.21M +$3.13M +151% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $5.08M +$2.63M +107% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $4.74M +$3.32M +234% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $3.52M +$1.86M +112% Dec 31, 2019 10-K 2021-03-11
Q3 2019 $2.08M Sep 30, 2019 10-Q 2019-11-04
Q2 2019 $2.45M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $1.42M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $1.66M Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.